Biocon gains on acquiring business assets of Acacia Lifesciences

05 Oct 2015 Evaluate

Biocon is currently trading at Rs. 454.30, up by 6.70 points or 1.50% from its previous closing of Rs. 447.60 on the BSE.

The scrip opened at Rs. 453.20 and has touched a high and low of Rs. 456.40 and Rs. 453.00 respectively. So far 4,186 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 508.75 on 07-Oct-2014 and a 52 week low of Rs. 396.50 on 25-Aug-2015.

Last one week high and low of the scrip stood at Rs. 456.40 and Rs. 433.00 respectively. The current market cap of the company is Rs. 9,084.00 crore.

The promoters holding in the company stood at 61.02% while Institutions and Non-Institutions held 19.91% and 19.06% respectively.

Biocon has acquired the business assets of the pharmaceutical manufacturing unit of Acacia Lifesciences located at Vishakapatnam with effect from October 01, 2015 on a going concern basis. This unit is presently manufacturing advanced intermediates of potent APIs useful to the company’s business as well as for supply to third party customers.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.


Biocon Share Price

390.50 0.25 (0.06%)
30-Dec-2025 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.80
Dr. Reddys Lab 1265.95
Cipla 1491.40
Zydus Lifesciences 902.30
Lupin 2081.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×